ClexBio Oversubscribes Financing Round Totalling USD 2.2M to Develop Engineered Human Blood Vessel Transplants
OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology
FREDsense Technologies Raises $2.5M from BDC Capital to Accelerate Their Biologically Based Water Quality Sensors.
Codex DNA Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome
